Navigation Links
Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
Date:10/3/2007

BOULDER, Colo., Oct. 3 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. (Nasdaq: TPPH) announced today that it has initiated a Phase 2 open- label, multi-center study of TPI 287 in patients with advanced pancreatic cancer. This is the second Phase 2 trial exploring the activity of TPI 287 in various tumor types: the first Phase 2 trial began earlier this year in advanced hormone refractory prostate cancer.

"Currently available taxanes are not approved for pancreatic cancer and effective treatment options for this difficult tumor are quite limited," commented Leonard Shaykin, chairman and chief executive officer of Tapestry Pharmaceuticals. "This pancreatic trial, combined with our experience in both the Phase 1 and in the Phase 2 trial currently running in refractory prostate cancer, will further characterize the safety and efficacy profile of TPI 287 in classically resistant and hard to treat tumors."

Trial Design

The pancreatic cancer trial for TPI 287 is a multi-center, open-label, single arm Phase 2 study for up to 65 patients with advanced stage, unresectable pancreatic cancer who have failed a prior gemcitabine-containing chemotherapy regimen for their disease. The trial will be conducted in approximately 10 to 15 centers in the U.S., Europe and India. Patients will receive TPI 287 administered as a 60 minute (+/- 10 min) IV infusion.

The primary endpoint of the trial will be the six-month survival (percent of patients alive at six months after starting the study). Secondary efficacy endpoints will be the six-month progression free survival (percent of patients whose disease has not advanced by six months), response to therapy (reduction in radiographically measurable disease as d
'/>"/>

SOURCE Tapestry Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007 AACR Annual Meeting
2. Malvern initiates European user group meetings for chemical imaging
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... 2014 In today,s increasingly global marketplace ... to reflect the needs of a global marketplace ... the needs of key stakeholders while recognizing regional ... According to recent research by benchmarking firm, Best ... companies averaged more than $100,000 in annual spending ...
(Date:12/19/2014)... December 18, 2014 Radiology ... that is used to store, manipulate, and distribute ... a patient tracking and scheduling system, result reporting, ... RIS with HIS and other databases improves the ... and patient scheduling, patient list management, radiology department ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... Dec. 22 Prasco Laboratories announced today that they have ... a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest ... of the agreement, Prasco will market and distribute Clobetasol Propionate ... under the Prasco label. , "We are pleased to provide ...
... , , SANTA CLARA, Calif., Dec. 22 NewCardio, Inc., ... today announced that Dr. Ihor Gussak, Ph.D., F.A.C.C., NewCardio,s Vice ... of speakers, moderators and panelists at the Center for Business ... is scheduled for January 12 and 13, 2010, at the ...
Cached Medicine Technology:Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam 2Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 2NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 4
(Date:12/19/2014)... (PRWEB) December 20, 2014 These vanadium ... and other nations. Around 151,000 tons of vanadium were ... The global vanadium usage increased at 6.7% AAGR during ... steel and iron industry, being the largest consumer, accounted ... 2013, followed by titanium-vanadium alloy and the chemical industry. ...
(Date:12/19/2014)... 2014 (HealthDay News) -- New research warns parents that buying an ... risk. Nearly half of teen drivers killed in the United ... least 11 years old and often lacked important safety features that ... of teen drivers killed in crashes were in cars at least ... years old, 31 percent were in cars 11 to 15 years ...
(Date:12/19/2014)... (HealthDay News) -- Injectable drug users who also use ... rate of other substance users, a new study finds. ... the risk of suicide attempt and completed suicide," Didier ... said in a university news release. "However, there are ... know who among substance users were actually more likely ...
(Date:12/19/2014)... Surviving Mesothelioma says thousands of water pipes in ... pipes can leach asbestos into drinking water as they age. ... on the Surviving Mesothelioma website. , According to the ... decaying water mains made of asbestos cement are the major ... protect consumers from mesothelioma , water providers are subject to ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 B. E. ... to healthcare providers, has been retained to lead a ... Memorial Hospital in Franklin, Ind. The top executive search ... recently placed more than 900 healthcare executives into organizations. ... full service hospital providing care to the residents of ...
Breaking Medicine News(10 mins):Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3
... Researchers say cases go up in the warm-weather months when ... Air pollution is already linked to respiratory and cardiovascular ills, ... also cause appendicitis. , Authors of a new study published ... Association Journal found that cases of appendicitis go up ...
... to a clinical study released in The American Journal ... Pomegranate Juice may decrease the progression of arterial plaque in ... was intended to see if POM Wonderful 100% Pomegranate Juice ... artery (CIMT) in patients with moderate coronary heart disease risk. ...
... This year you can wear your Halloween costume twice while ... turn out in their favorite super hero costumes to raise ... Super Jake & Friends Heroes Bash on Saturday, ... benefit The Super Jake Foundation. , "The five-year ...
... China, Oct. 5 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,(Nasdaq: ... firm,specializing in the manufacture, research, development, marketing and,distribution ... its,previously announced underwritten public offering. The Company sold ... share in its public offering,resulting in approximately $65.5 ...
... Oct. 5 Everybody feels stressed at some point in their ... day: deadline pressures at work, financial concerns when a 401 (k) ... sick child, aging parents, and money woes -- just to name ... , It,s very easy to get stressed out over ...
... the patients who die in intensive care units die within ... good end-of-life care. Most relatives are nevertheless happy with the ... the University of Gothenburg, Sweden. An intensive care unit ... end-of-life care. When a patient dies on an ICU, this ...
Cached Medicine News:Health News:Air Pollution May Cause Appendicitis: Study 2Health News:Air Pollution May Cause Appendicitis: Study 3Health News:8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds 2Health News:8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds 3Health News:Super Jake Foundation Hosts 5th Annual Heroes Bash on Nov. 14 to Benefit Pediatric Cancer Research 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 3Health News:VIDEO from Medialink and CIGNA: Don't Stress Out Over Stress, Some of it is Good for You 2Health News:Intensive care units poorly equipped to care for the dying 2
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... aspiration holes and additional electrode tip ... precise dissection with decreased risk of ... ,Flexible design options allow the ... and multiple tip designs. Optimize specific ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: